This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
The study sample was appropriate for the clinical study question since the study population was limited to adolescents with specific morbidity characteristics, as were those in the study sample. Both the intervention and control groups consisted initially of 35 patients each. However, 5 modem patients and 2 control patients were discontinued from the study due to non-compliance with the protocol, such as not transmitting glucose data (5 patients) and the inability to attend the 3-month clinic (2 patients). There was no significant difference in the discontinuation rate between the two groups (chi-squared, p=0.232). Therefore, 63 patients (30 in the modem group and 33 in the control group) completed the study.
Study design
The study was a randomised controlled trial that was carried out in a single centre. Each patient was randomly assigned to either the modem group or the control group. The method of randomisation was not stated. The duration of followup was 6 months. Apart from 7 patients who discontinued due to non-compliance, there was no further loss to followup. The outcome assessment was not blinded.
Analysis of effectiveness
The analysis of the clinical study was deliberately based on treatment completers only rather than "intention to treat" because the authors felt that, in the latter case, the costs for the modem group would have been falsely lowered. In addition, because follow-up data were not available for those who discontinued, the "last observation carried forward" was not applicable for statistical analysis.
The clinical outcomes assessed in the study were the GHbA1c values and the incidence of hypoglycaemia and diabetic ketoacidosis. Also evaluated were compliance with blood glucose testing and data transmission, and the degree of patient satisfaction. To estimate patient satisfaction, the participants were given a questionnaire at the end of the study, concerning overall satisfaction with the diabetes care received during the study. The patient groups were shown to be comparable in terms of their gender, age, duration of diabetes, and initial GHbA1c levels (p>0.05 for all parameters). The analysis was further adjusted to take patients with initial GHbA1c levels of at least 9% into consideration.
Effectiveness results
The mean baseline GHbA1c values were 9.0% (+/-1.2) for the modem group and 8.9% (+/-1.1) for the control group, (t-test, p=0.89).
The GHbA1c levels significantly decreased in both groups during the 6 months, although the difference between the groups was not statistically significant. The mean, final GHbA1c value was 8.6% (+/-1.7) for the modem group and 8.6% (+/-1.2) for the control group, (t-test, p=0.96). There were also no significant differences between sub-groups with initial GHbA1c values of at least 9.0%.
The occurrence of diabetic ketoacidosis and hypoglycaemic events were also similar in the two groups. One patient in each group had several episodes of diabetic ketoacidosis, while another in each group had an episode of mild diabetic ketonuria that did not require hospitalisation.
Mild-to-moderate hypoglycaemia occurred, on average, 1.5 times/week in the modem group and 1.4 times/week in the control group, (t-test, p=0.71). No episodes of severe hypoglycaemia were reported in either group.
Test compliance was similar in the two groups, (t-test, p=0.91).
Both groups expressed high satisfaction with the overall diabetes care during the study, (p=0.81).
Clinical conclusions
There was no significant difference in GHbA1c values, incidence of hypoglycaemia and diabetic ketoacidosis, test compliance, or patient satisfaction between the modem and the control groups.
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Measure of benefits used in the economic analysis
The authors demonstrated that the clinical outcomes assessed in the study were not significantly different between the two groups. Thus, no summary measure of benefits was used in the economic analysis and the analysis was based on cost differences only (i.e. cost-minimisation analysis).
Direct costs
The perspective adopted in the study was not stated, but the analysis included both the health service costs and non health care costs.
For the modem group, the direct costs were for the modem and computer, the training of a registered nurse to use the modem and transmission data (and subsequently train the patient or parents), staff, institutional overheads, and the patients' phone expenses. The modem and computer cost was amortised over an average lifespan of 3 years with usage of 6 months. The staff costs were for health care professionals (mainly nurses) who downloaded data and had phone conversations. The quantities and the costs were analysed separately for the staff costs (the health professionals' time was multiplied by the average wage). Modem, staff and patient costs were derived from actual data, whereas computer, overhead and training costs were estimated.
For the control group, the direct costs consisted of the aggregate cost of a 3-month clinic visit paid by the family or an insurance company (the range of time of a visit was reported), and additional patient costs such as parking, mileage, meals, hotel stay and babysitting. The patients were asked to complete an expense log that itemised their costs. It was not stated whether the costs of visits for the control group were based on actual resource use or reflected charges.
The dates to which the resources and prices for both groups referred were not reported. Discounting was not carried out, but this was appropriate as the costs were calculated a 6-month period.
Statistical analysis of costs
A range of health care costs and patient costs was provided for the control group only. An average cost per cost component was reported for the modem group. No results of statistical tests were presented in the cost analysis, apart from a comparison of the total costs in the two groups.
Indirect Costs
The indirect costs were included only in the modem group costs, to account for time the patients and their parents missed from school and work. Nevertheless, the time losses in the control group were also reported, although they did not lead to the calculation of indirect costs for this patient group. The time spent by the patient or parent in the modem group in training, talking to a care provider, and entering and transmitting data via the modem, was reported separately from the unit cost attached to every hour spent. The time was estimated from actual data. However, no explicit justification was given for the value chosen for the unit cost attached (which was common to both the patients and their parents). The dates to which the time and unit cost referred were not stated. Discounting was not relevant since the costs were estimated for a 6-month period.
